The Efficacy of Using a Rapid Diagnostic Test in Active Cases Finding of COVID-19 Infection in Community by Public Health Workers
Main Article Content
Abstract
Background and Objectives: The efficacy of Rapid Diagnostic Tests (RDTs) in diagnosing COVID-19 through active case finding depends on several factors, including the skill of specimen collection, test performance, and interpretation of results. This study assessed the efficacy of RDTs in diagnosing COVID-19 in active cases finding in a community-based practice by public health workers who received appropriate training.
Design: A retrospective cross-sectional study
Methods: This retrospective cross-sectional study was conducted at a temporary active case finding site in a community on August 10, 2021. Public health workers trained with a three-hour session including hands-on practice performed RDTs under the supervision of trained medical doctors. The testing was done by the public health workers from preparing RDTs to interpreting the test results. RDTs’ efficacy was compared with RT-PCR results performed in the same visit.
Results: Out of 163 participants who had close contact with COVID-19 patients, 26 participants (16% of the total samples) had positive RT-PCR results. The testing showed a sensitivity of 88% (95% confidence interval 77% to 100%) and a specificity of 100% (100% to 100%). Subgroup analysis based on the presence of symptoms revealed no significant difference in the sensitivity and specificity of both groups. The sensitivity of RDTs in the symptomatic group was 86% (57% to 100%), and 89% (74% to 100%) in the asymptomatic group. Furthermore, the average cycle-time value of RT-PCR testing was above 30 for the samples that tested negative with the RDT.
Conclusions: Using RDTs for active case findings of COVID-19 by public health workers was found to be comparably effective to RT-PCR testing during the pandemic while being less time-consuming and labor-intensive. Additionally, public health workers with limited experience in nasal swabbing and RDTs can be trained to effectively use these tools and help increase access to care and promote timely disease control.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The content and information in articles published in the PCFM journal are solely the opinions and responsibilities of the authors. The journal's editorial board does not necessarily agree with or share any responsibility for them.
All articles, information, content, images, etc., published in the PCFM journal are the copyright of the PCFM journal. If any individual or organization wishes to reproduce, distribute, or use any part or the entirety of the content, they must obtain written permission from the PCFM journal beforehand.
References
สถานการณ์โรคติดเชื้อไวรัสโคโรนา 2019 (COVID-19) มาตรการสาธารณสุข และปัญหาอุปสรรคการป้องกันควบคุมโรคในผู้เดินทาง. งานโรคติดต่ออุบัติใหม่ กลุ่มพัฒนาวิชาการโรคติดต่อ.[Internet]. [cited 2564 สิงหาคม 18]. Available from: https://ddc.moph.go.th/uploads/files/2017420210820025238.pdf
การตรวจวินิจฉัยโรคติดเชื้อไวรัสโคโรนา 2019. กรมวิทยาศาสตร์การแพทย์.[Internet]. [cited 2020 ตุลาคม 16]. Available from: http://nih.dmsc.moph.go.th/data/data/64/covid/covid_lab16102020.pdf
อาชวินทร์ โรจนวิวัฒน์ และคณะ. การประเมินประสิทธิภาพของชุดทดสอบตรวจหาแอนติบอดีต่อ SARS-CoV-2 ในประเทศไทย. วารสารกรมวิทยาศาสตร์การแพทย์ ปีที่ 62; ฉบับที่ 3: 220-230.
Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand [internet]. Chutikarn Chaimayo 1, Bualan Kaewnaphan 1, Nattaya Tanlieng 1, Niracha Athipanyasilp 1, Rujipas Sirijatuphat 2, Methee Chayakulkeeree 2, Nasikarn Angkasekwinai 2, Ruengpung Sutthent 1.[cited 2020 Nov 13] Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665091/
Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients. Ignacio Torres 1, Sandrine Poujois 1, Eliseo Albert 1, Javier Colomina 1, David Navarro 2. [Internet]. [cited 2021 Jan 6]. Available from: https://pubmed.ncbi.nlm.nih.gov/33421573/
Diagnostic accuracy of rapid antigen tests in asymptomatic and presymptomatic close contacts of individuals with confirmed SARS-CoV-2 infection: cross sectional study. Ewoud Schuit 1 2, Roderick P Venekamp 1, Lotty Hooft 1. [Internet]. [cited 2021 Jul 27]. Available from: https://pubmed.ncbi.nlm.nih.gov/34315770/
WORLD METEOROLOGICAL ORGANIZATION Weather · Climate · Water. Valencia. [Internet]. [cited 2022 Jun 17]. Available from: https://worldweather.wmo.int/en/city.html?cityId=1238
Hajian-Tilaki K. Sample size estimation in diagnostic test studies of biomedical informatics. Journal of Biomedical Informatics 48 (2014): 193–204.
abbott: Panbio™COVID-19 Ag Rapid Test Device (NASOPHARYNGEAL) In vitro diagnostic rapid test for qualitative detection of SARS-CoV-2 antigen (Ag). Abbott Rapid Diagnostics Jena GmbH. [Internet]. [cited 2020 08]. Available from: https://cdn.who.int/media/docs/default-source/in-vitro-diagnostics/eul-0564-032-00-panbi-covid19-ag-rapid-test-device.pdf?sfvrsn=32f579d9_2&download=true
Department of Disease Control, Ministry of Public Health. Investigation form for patients infected with the novel coronavirus disease 2019 (Novelcorona 2) [updated cited April 11, 2021] Available from: https://ddc.moph.go.th/viralpneumonia/g_form.php
แนวทางการดำเนินงานคัดกรอง เฝ้าระวัง และสอบสวนโรคติดเชื้อไวรัสโคโรนา 2019 (COVID-19) (Coronavirus Disease 2019: COVID-19). กรมควบคุมโรค. [Internet]. [cited 4 ธันวาคม 2563] Available from: https://ddc.moph.go.th/viralpneumonia/file/g_srrt/g_srrt_041263.pdf
Baro B, Rodo P, Ouchi D. Performance characteristics of five antigen-detecting rapid diagnostictest (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison. Journal of Infection 82 (2021): 269–275.